FDA Revokes Emergency Authorization On Ebola, Zika Tests
Emergency Use Authorizations on two Ebola tests and one for the Zika virus have been revoked by the US agency because it cleared the tests via more permanent pathways.
You may also be interested in...
Three US health-care agencies – FDA, the Centers for Disease Control and Prevention, and the Centers for Medicare and Medicaid Services – set up a “Tri-Agency Task Force for Emergency Diagnostics” to rapidly push effective emergency-use tests into the field when outbreaks of Ebola, Zika, Influenza or similar health threats occur in the US or globally.
A group of manufacturers and clinicians is asking the US agency to allow more discussion between manufacturers, labs and clinicians of how genetic factors could influence drug effectiveness – an area known as pharmacogenomics (PGx). The FDA had previously taken several steps to limit these communications.
The US FDA says Bayer has successfully recovered unsold Essure units and completed enrollment in a Sec. 522 postmarket study, fulfilling deadlines set at a year from the date the devices were taken off the US market.